2026

Home >> 2026 >> Page 4
Feature image not available
09.03.2026

Image modifications reduce differences in natural-image encoding by retinal ganglion cells between natural and optogenetic stimulation

Authors Ramakrishna V, Gollisch T Journal BioRxiv Citation bioRxiv 2026.03.06.710066. Abstract Photoreceptor degeneration is among the leading causes of blindness and optogenetics as a potential therapeutic measure has garnered much attention over recent years. In this approach, light-sensitive molecules like Channelrhodopsin-2 (ChR2) are inserted into neurons in the retina to
Learn More
Feature image not available
06.03.2026

Structural remodeling of the mitochondrial protein biogenesis machinery under proteostatic stress

Authors Ehses K, López-Alonso JP, Antico O, Azem A, Muqit MMK, Ubarretxena-Belandia I, Fernández-Busnadiego R Journal Science Advances Citation Sci Adv. 2026. Sci Adv. 2026 Mar 6;12(10):eaed3579. Abstract Cells have evolved organelle-specific responses to maintain protein homeostasis (proteostasis). During proteostatic stress, mitochondria down-regulate translation and enhance protein folding, yet the
Learn More
Feature image not available
06.03.2026

A transition-prone brain state precedes spontaneous behavioral switching

Authors Wanken P, Edelman BJ, Behera L, Martinez de Paz JM, McCarthy PT, Macé E Journal BioRxiv Citation bioRxiv 2026.03.06.709845. Abstract Animals exhibit behavior in the absence of external stimuli or explicit tasks. Is the initiation of such spontaneous behavior shaped by internal brain states in a predictable manner? If
Learn More

Heart muscle cells cultivated in the laboratory from iPS cells: The image shows the structure of the muscle fibres. The project at Göttingen University Medical Centre (UMG), funded by the zukunft.niedersachsen programme, works with such patient-specific models. Image: umg/lukas cyganek

03.03.2026

Precision medicine for rare heart diseases

Göttingen research receives millions in funding   The University Medical Center Göttingen (UMG) is receiving over one million euros from the zukunft.niedersachsen funding programme for a gene therapy project to treat Noonan syndrome. The focus is on developing individually tailored therapies for children with heart disease.   Rare diseases often
Learn More

Super-resolution image of cytoskeleton and focal adhesion proteins taken using the new versatile and cost-effective microfluidics system. The “overlay” of all the different target molecules reveals exquisite and complex detail up to 100 times sharper than conventional microscopy. Photo: adapted from the original publication in ACS Nano (2026). DoI: 10.1021/acsnano.5c18697

03.03.2026

Tiny flows, big insights: microfluidics system boosts super-resolution microscopy

International research team led by Göttingen University design versatile imaging system   Understanding how cells are organized and how their molecular components interact in a coordinated and cooperative manner is a central goal of modern life sciences. To answer these questions, researchers need to observe many structures inside the same
Learn More
Feature image not available
03.03.2026

Mechanism of human tRNA 3′CCA maturation

Authors Kuhle B, Krebs L, Bhatta A, Dennerlein S, Rehling P, Hillen H Journal BioRxiv Citation bioRxiv 2026.03.02.709036. Abstract The non-templated addition of the 3′CCA end is the final universal step of tRNA maturation. In humans, 3′CCA addition on nuclear- (nu-tRNA) and mitochondria-encoded tRNAs (mt-tRNA) is catalyzed by a single
Learn More
Feature image not available
02.03.2026

Nanobodies equipped with HaloTag variants enable rapid and straightforward one-step immunofluorescence lifetime multiplexing

Authors Albert L, Basak S, Koerner H, Oleksiievets N, Mougios N, Cotroneo ER, Frei MS, Enderlein J, Broichhagen J, Simeth NA, Tsukanov R, Opazo F Journal BioRxiv Citation bioRxiv 2026.03.02.709025. Abstract Multiplexed fluorescence imaging is limited by spectral overlap, whereas fluorescence lifetime provides an orthogonal encoding dimension. We replace genetically
Learn More

The team behind Ovo Labs (from left)- Dr. Agata Zielinska, Prof. Dr. Melina Schuh, and Dr. Oleksandr Yagensky. © Irene Böttcher-Gajewski _ Max Planck Institute for Multidisciplinary Sciences

23.02.2026

Ovo Labs receives Max Planck Startup Award of the Stifterverband 2026

This year’s Max Planck Start-up Award of the Stifterverband honours the work of Ovo Labs. Founded in 2025 as a spin-off from the Max Planck Institute for Multidisciplinary Sciences in Göttingen, the young biotech company develops novel therapeutics designed to improve the quality of human oocytes (egg cells). The prize,
Learn More
Feature image not available
20.02.2026

Structures of the 26S proteasome in complex with the Hsp70 co-chaperone Bag1 reveal a mechanism for direct substrate transfer

Authors Maestro-López M, Cheng TC, Muntaner J, Menéndez M, Alonso M, Schweitzer A, Ishizaka M, Tomko RJ Jr, Cuéllar J, Valpuesta JM, Sakata E Journal Science Advances Citation Sci Adv. 2026 Feb 20;12(8):eadz3026. Abstract Coupling between the chaperone and degradation systems, particularly under stress, is essential for eliminating unfolded proteins.
Learn More
X
EN DE
X
X